Search results
216 Results for 'Cancer'
- Technologies (22)
- Collaborations (1)
- Team (0)
- News (145)
- Pages (0)
- Multimedia (48)
- Publications (0)
- Jobs (0)
- Events (0)
Technologies 22
-
DoriVac: DNA Origami-Based Vaccines for Combination Immunotherapy
Personalized cancer and infectious disease vaccine platform harnessing DNA nanotechnology to control the co-delivery and co-presentation of tumor antigen and adjuvant ligands to immune cells with nanoscale precision. This approach has potential to trigger enhanced immune responses against tumors and infectious pathogens. -
Metabolically Labeled CAR-T Cells Against Cancer
Through a simple and effective metabolic labeling approach, patient-derived T cells engineered to carry immune-enhancing cytokines on their surfaces could help expand adoptive T cell therapies to treatment of solid tumors and improve blood cancer therapies. -
AminoX: Making Better Protein Drugs, Quicker and Cheaper
AminoX enables protein drugs to only become active in the tumor microenvironment and not elsewhere in the body to avoid immune-related adverse effects in the body. By designing and building non-standard amino acids into strategic positions of protein drugs, AminoX provides tumor-specific, and longer-lasting target inhibition. -
ReConstruct: Vascularized Tissue for Breast Reconstruction and Augmentation
ReConstruct is a platform for growing, vascularizing, and implanting patient-derived tissues that enable safer breast reconstruction after cancer surgery. -
NodeTX: Growing Lymph Nodes to Treat Cancer
NodeTX is a novel immunotherapy that leverages the human body's innate ability to grow lymph nodes to fight tumors. -
Cellular “Backpacks” to Fight Cancer, Autoimmune Disorders, and More
Macrophages are very malleable immune cells, but that also means that they can be influenced by cancerous tumors and inflammatory processes. Our cellular "backpacks" stick to macrophages and can deliver molecules that keep them in their desired state for cell therapy and more.
Collaborations 1
i3 Center: Biomaterials to Create T Cell ImmunityNews 145
Multimedia 48
-
Video/AnimationDavid Mooney on the Mission to Save Lives Through Cancer ResearchDavid Mooney, Core Faculty member of the Wyss Institute and Robert Pinkas Family Professor of Bioengineering in the Harvard School of Engineering and Applied Sciences, discusses training immune cells to recognize and destroy cancer mutations. While current immunotherapies create nearly miraculous cures for some patients, they only work for certain cancers and a fraction of... -
Video/AnimationReimagining a World Without Terminal IllnessAs he battles metastatic skin cancer, Wyss Scientific Instrument maker John Caramanica is more motivated than ever to do his part in fabricating technologies to improve the health of others and our planet. Credit: Wyss Institute at Harvard University -
Video/AnimationLet’s talk about women’s healthWhen promoting the ReConstruct technology, which improves the lives of patients undergoing breast reconstruction, our social media team found that the use of the word “breast” was deemed as “inappropriate” by the algorithms of certain social media sites. Thus, these posts performed more poorly than similar posts. Without the ability to talk openly about Women’s... -
Video/Animation20-ish Questions with Natalie Artzi20-ish Questions shows a different side of Wyss Institute faculty, touching on aspects of their personal life, hobbies, interests, as well as their research. This round follows Natalie Artzi, a new addition to the Wyss Institute’s Core Faculty. Credit: Wyss Institute at Harvard University -
Video/AnimationProgress, Potential, and Possibilities with Luba Perry, Ph.D. – Bioengineered Breast Reconstruction And AugmentationEach episode of this podcast includes a discussion with fascinating people designing a better tomorrow. Luba Perry, Ph.D. is Co-Founder and CEO of ReConstruct Bio, an innovative venture emerging from Harvard’s Wyss Institute, aimed at redefining the fields of medical reconstruction and aesthetics with an initial application of their groundbreaking technology on breast reconstruction and... -
Video/AnimationDoriNano – Improved DNA Origami Nanodelivery to Fight Cancer and Other DiseasesWe’re developing DNA Origami nanodelivery, which is transforming nanoparticle industry. Developed at the Dana Farber Cancer Institute and the Wyss Institute at Harvard University, this innovative approach overcomes the challenges of other nanoparticles, offering stability, high drug loading capacity, nano-scale control of cargo spacing, and more – making it a highly customizable solution for delivering...